安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Cime Therapeutics
Cime combines recent advancements in automation, AI ML, and synthetic chemistry allowing us to make molecules faster, more efficient, and more cost effective than current solutions
- Colorado start-up launches to improve drug discovery chemistry
Colorado-based Cime Therapeutics has emerged from stealth with $2 1 million in preseed financing to advance its method for efficiently synthesizing and screening molecules that could become
- Cime Therapeutics - LinkedIn
We combine the synthesis and screening stages of drug discovery to accelerate the Design-Make-Test-Analyze paradigm Cancer remains a complex challenge in medicine, demanding precision at every
- Cime Therapeutics 2026 Company Profile: Valuation, Funding . . . - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Cime Therapeutics Use the PitchBook Platform to explore the full profile
- Cimeio Therapeutics - Transforming Hematopoietic Stem Cell Transplant . . .
Using our cell-shielding technology and paired immunotherapies, we aim to develop curative therapies for patients with hematologic disorders Our proprietary immunotherapies deplete diseased cells, while our cell-shielding technology protects healthy cells
- Cime Therapeutics - 2026 Company Profile Team - Tracxn
Cime Therapeutics is a seed company based in Boulder (United States), founded in 2024 by James Brewster It operates as an A biotechnology company focused on advancing drug discovery through a chemistry-first platform
- EDGAR Filing Documents for 0002062575-25-000001 - SEC. gov
Document Format Files Mailing Address 110 16TH STREET SUITE 1460 DENVER CO 80202 Business Address 110 16TH STREET SUITE 1460 DENVER CO 80202 760-703-5380 Cime Therapeutics Inc (Filer) CIK: 0002062575 (see all company filings) EIN 021-541875
- Cime Therapeutics Inc. · 110 16th Street, Suite 1460, Denver, CO 80202
Cime Therapeutics Inc (Entity # 20251191810) is a FPC in Denver, Colorado registered with the Colorado Department of State (CDOS) The entity was formed on February 20, 2025 in the jurisdiction of Delaware
|
|
|